Kyruus Secures $25 Million Funding to Expand Referral Coordination Platform Amid Dominance of 36 Apps in Global Mobile Health Market

1, Global 16360,000 Mobile Health Apps"Domestic Companies Account for Half the Market"

According to a survey report on mobile health apps released by the IMS Institute, the number of mobile health apps in the global Apple App Store and Google Play Store reached 165,000, among which the downloads of 36 apps accounted for half of the total downloads of all mobile health apps.

A detailed study by the IMS Institute of 26,000 apps revealed that one in ten apps features connectivity with product hardware to enhance user data feedback channels and facilitate data collection. Over the past two years, the integration rate of mobile health apps with social networks has increased from 26% to 34%, while there has been little improvement in the security of app interfaces with healthcare service systems and electronic medical records.



2、Zoll 3500Acquired Israeli Wearable Cardiac Monitor Manufacturer for USD Million

Recently, ZOLL Medical Corporation acquired Kyma Medical Technologies, an Israeli manufacturer of wearable cardiac devices, for $35 million. Kyma designs wearable remote monitoring devices for patients with congestive heart failure.

Kyma’s CE-certified µ-Cor system attaches to the torso and utilizes wireless radiofrequency technology to monitor pulmonary fluid accumulation, while collecting data on heart rate, respiratory rate, activity, and posture. The company has identified that fluid buildup in the lungs is one of the most severe consequences of congestive heart failure, which can be managed with medication if detected early.

Zoll’s acquisition of Kyma Medical aims to broaden its product portfolio, incorporate new technologies, and improve therapeutic outcomes for heart failure patients with fluid accumulation issues. Furthermore, leveraging Zoll’s existing network will enable Kyma’s technology to better penetrate the global market. Additionally, Zoll seeks to capitalize on Kyma’s strong R&D capabilities in Israel and its broader pool of research talent.



3, Referral Coordination Platform Company KyruusObtained 2,500$10,000 in financing

Recently, the SaaS-based referral coordination platform secured $25 million in funding. Kyruus primarily helps hospitals optimize their online patient entry points and referral management. This round of financing was led by New Leaf Venture Partners.

Kyruus will use the funds to expand its user base and operations team, as well as increase investment in optimizing its product platform interface, including patient-facing search interfaces, online scheduling, network analytics, and patient relationship management.



4, Huawei and BGI Jointly Develop Genomic Big Data Storage System

Recently, at the Huawei Cloud Computing Conference 2015, Huawei and BGI signed the "Joint Development Agreement on Gene Big Data Storage System." The two parties will jointly design and develop a big data storage system optimized for gene research, targeting the characteristics of gene processing workflows, to eliminate redundant data in gene research workflows and improve overall efficiency by more than 30%.

Yang Shuang, CEO of BGI Genomics, stated, “Big data and cloud computing technologies are crucial pathways for accelerating the output and application of genomic research findings. We hope that our joint innovation with Huawei will elevate the efficiency of genomic research to a new level.”



5JD Daojia and Kangzhijia Enter into Strategic PartnershipBuilding a Pharmaceutical O2O ModelPlatform

Recently, JD Daojia, the O2O platform under JD.com, has entered into a strategic partnership with the chain pharmacy Kangzhijia.

The two parties will use “pharmaceuticals” as the entry point, covering a wide range of categories for household staple and urgent-care medications to comprehensively meet users’ medication needs. In addition to pharmaceuticals, they will engage in in-depth collaboration across five major health categories, including medical devices, pharmaceutical packaging materials, health supplements, medical equipment, and adult products.

According to Zhang Liujing, Chairman of Kangzhijia Online Pharmacy, the decision to enter into a strategic partnership with JD Daojia was driven by its speed and channel advantages in logistics, which ensure the convenience and timeliness of medication purchases for customers. Meanwhile, JD Daojia values Kangzhijia’s extensive offline network of nearly 2,000 chain experience pharmacies and its strong advantages in pharmaceutical distribution rights.